Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endothelial and smooth muscle cell-derived neuropilin-like protein
(
ESDN
) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define
ESDN
function in primary human VSMCs.
ESDN
down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased
ERK1
/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFRbeta expression levels. In binding assays,
ESDN
down-regulation significantly increased (125)I-PDGF maximum binding (B(max)) to PDGF receptors on VSMCs without altering the binding constant (K(d)), raising the possibility that
ESDN
regulates PDGFR processing.
ESDN
down-regulation significantly reduced ligand-induced PDGFRbeta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFRbeta. Thus,
ESDN
modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The
ESDN
effect is mediated, at least in part, through effects on PDGFRbeta ubiquitination.
ESDN
may serve as a target for regulating PDGFRbeta signaling in VSMCs.
...
PMID:Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination. 1969 27
Insulin effects on cell metabolism, growth, and survival are mediated by its binding to, and activation of, insulin receptor. With increasing prevalence of insulin resistance and diabetes there is considerable interest in identifying novel regulators of insulin signal transduction. The transmembrane protein
endothelial and smooth muscle cell-derived neuropilin-like protein
(
ESDN
) is a novel regulator of vascular remodeling and angiogenesis. Here, we investigate a potential role of
ESDN
in insulin signaling, demonstrating that Esdn gene deletion promotes insulin-induced vascular smooth muscle cell proliferation and migration. This is associated with enhanced protein kinase B and
mitogen-activated protein kinase
activation as well as insulin receptor phosphorylation. Likewise, insulin signaling in the liver, muscle, and adipose tissue is enhanced in Esdn(-/-) mice, and these animals exhibit improved insulin sensitivity and glucose homeostasis in vivo. The effect of
ESDN
on insulin signaling is traced back to its interaction with insulin receptor, which alters the receptor interaction with regulatory adaptor protein-E3 ubiquitin ligase pairs, adaptor protein with pleckstrin homology and Src homology 2 domain-c-Cbl and growth factor receptor bound protein 10-neuronal precursor cell-expressed developmentally downregulated 4. In conclusion, our findings establish
ESDN
as an inhibitor of insulin receptor signal transduction through a novel regulatory mechanism. Loss of
ESDN
potentiates insulin's metabolic and mitotic effects and provides insights into a novel therapeutic avenue.
...
PMID:The neuropilin-like protein ESDN regulates insulin signaling and sensitivity. 2692 37